Bank Hapoalim BM’s SteadyMed Ltd STDY Stock Holding History

Bank Hapoalim BM’s Portfolio STDY Stock Details STDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,000	Closed	-$54K	–	204
2018 Q2	$54K	Hold	12,000	–	–	0.01%	187
2018 Q1	$39K	Hold	12,000	–	–	0.01%	188
2017 Q4	$44	Hold	12,000	–	–	0.01%	193
2017 Q3	$40K	Hold	12,000	–	–	0.01%	213
2017 Q2	$76K	Buy	+12,000	New	+$81.6K	0.02%	207

Other funds holding STDY

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return

HCMT

Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

TCOV

Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return

Bank Hapoalim BM's STDY Position: Q3 2018 in Review

Bank Hapoalim BM sold out of SteadyMed Ltd (STDY) in Q3 2018, closing a stake of 12,000 shares — an estimated $54K sold.

Bank Hapoalim BM first reported a position in STDY in Q2 2017 and held it in 5 quarters. The position peaked at $76K in Q2 2017. 5 funds tracked by Wall St. Rank hold STDY as of Q3 2018.

Bank Hapoalim BM reported no remaining SteadyMed Ltd position as of Q3 2018 after selling out during the quarter.
Bank Hapoalim BM sold 12,000 SteadyMed Ltd shares in Q3 2018, an estimated $54K.
Bank Hapoalim BM first reported a position in SteadyMed Ltd in Q2 2017 and held it in 5 quarters.
Bank Hapoalim BM's SteadyMed Ltd position peaked at $76K in Q2 2017.
5 funds tracked by Wall St. Rank held SteadyMed Ltd as of Q3 2018.

Based on Bank Hapoalim BM's 13F filing for Q3 2018, filed 8 Nov 2018.